H-1B sponsorship profile: Regeneron Pharmaceuticals, Inc. Across U.S. Department of Labor LCA disclosures, Regeneron Pharmaceuticals, Inc filed 449 Labor Condition Applications covering 449 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 98.9% (444 certified of 449 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Regeneron Pharmaceuticals, Inc’s H-1B petitions range from $69,680 at the low end to $365,000 at the high end, with a petition-weighted average of $150,045. That range reflects the mix of occupations the company sponsors, led by Senior Scientist (33 petitions at $137,294 avg), followed by Principal Scientist and Associate Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Regeneron Pharmaceuticals, Inc is headquartered in Tarrytown, NY under NAICS code 54171, and places H-1B workers across 5 states, most heavily in NY, NJ, MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Regeneron Pharmaceuticals, Inc ranks. By H-1B petition volume, Regeneron Pharmaceuticals, Inc is #415 of 119,880 employers nationally and #39 of 14,719 employers headquartered in NY. Both ranks are computed live from the same underlying petition counts, not a separate estimate.